CLINICAL ENFLURANE METABOLISM BY CYTOCHROME-P450 2E1

被引:56
作者
KHARASCH, ED
THUMMEL, KE
MAUTZ, D
BOSSE, S
机构
[1] UNIV WASHINGTON, DEPT MED CHEM, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT PHARMACEUT, SEATTLE, WA 98195 USA
关键词
D O I
10.1038/clpt.1994.53
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Fluorinated ether anesthetic hepatotoxicity and nephrotoxicity are mediated by cytochrome P450-catalyzed oxidative metabolism. Metabolism of the volatile anesthetic enflurane to inorganic fluoride ion by human liver microsomes in vitro is catalyzed predominantly by the cytochrome P450 isoform CYP2E1. This investigation tested the hypothesis that P450 2E1 is also the isoform responsible for human enflurane metabolism in vivo. Disulfiram, which is converted in vivo to a selective inhibitor of P450 2E1, was used as a metabolic probe for P450 2E1. Methods: Twenty patients undergoing elective surgery were randomized to receive disulfiram (500 mg orally; n = 10) or nothing (control subjects; n = 10) the evening before surgery. Ah patients received a standard anesthetic of enflurane (2.2% end-tidal) in oxygen for 3 hours. Blood enflurane concentrations were measured by gas chromatography. Plasma and urine fluoride concentrations were quantitated by ion-selective electrode, Results: Patient groups were similar with respect to age, weight, gender, duration of surgery, and blood loss. Total enflurane dose, measured by cumulative end-tidal enflurane concentrations (3.9 to 4.1 MAC-hr) and by blood enflurane concentrations, was similar in both groups. Plasma fluoride concentrations increased fi om 3.6 +/- 1.5 mu mol/L (baseline) to 24.3 +/- 3.8 mu mol/L (peak) in untreated patients (mean +/- SE). Disulfiram treatment completely abolished the rise in plasma fluoride concentration. Urine fluoride excretion was similarly significantly diminished in disulfiram-treated patients. Fluoride excretion in disulfiram-treated patients was 62 +/- 10 and 61 +/- 12 mu mol on days 1 and 2, respectively, compared with 1090 +/- 180 and 1200 +/- 220 mu mol in control subjects (p < 0.05 on each day). Conclusions: Disulfiram prevented fluoride ion production after enflurane anesthesia. These results suggest that P450 2E1 is the predominant P450 isoform responsible for human clinical enflurane metabolism in vivo.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 29 条
  • [1] EFFECTS OF DISULFIRAM ON HEPATIC P450IIE1, OTHER MICROSOMAL-ENZYMES, AND HEPATOTOXICITY IN RATS
    BRADY, JF
    XIAO, F
    WANG, MH
    LI, Y
    NING, SM
    GAPAC, JM
    YANG, CS
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (02) : 366 - 373
  • [2] THE EXTENT OF METABOLISM OF INHALED ANESTHETICS IN HUMANS
    CARPENTER, RL
    EGER, EI
    JOHNSON, BH
    UNADKAT, JD
    SHEINER, LB
    [J]. ANESTHESIOLOGY, 1986, 65 (02) : 201 - 205
  • [3] METABOLISM OF 2,2,2-TRIFLUOROETHANOL AND ITS RELATIONSHIP TO TOXICITY
    FRASER, JM
    KAMINSKY, LS
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 89 (02) : 202 - 210
  • [4] FRY BW, 1970, J LAB CLIN MED, V75, P1020
  • [5] GAUNTLETT IS, 1989, ANESTH ANALG, V69, P245
  • [6] OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES
    GUENGERICH, FP
    SHIMADA, T
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) : 391 - 407
  • [7] ROLE OF HUMAN CYTOCHROME-P-450-IIE1 IN THE OXIDATION OF MANY LOW-MOLECULAR-WEIGHT CANCER SUSPECTS
    GUENGERICH, FP
    KIM, DH
    IWASAKI, M
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (02) : 168 - 179
  • [8] HYLAND R, 1992, MOL PHARMACOL, V41, P259
  • [9] A REVIEW OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DISULFIRAM AND ITS METABOLITES
    JOHANSSON, B
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1992, 86 : 15 - 26
  • [10] IDENTIFICATION OF CYTOCHROME-P450 2E1 AS THE PREDOMINANT ENZYME CATALYZING HUMAN LIVER MICROSOMAL DEFLUORINATION OF SEVOFLURANE, ISOFLURANE, AND METHOXYFLURANE
    KHARASCH, ED
    THUMMEL, KE
    [J]. ANESTHESIOLOGY, 1993, 79 (04) : 795 - 807